Related Experiment Video
Updated: May 23, 2026
05:08
Targeted and Selective Treatment of Pluripotent Stem Cell-derived Teratomas Using External Beam Radiation in a Small-animal Model
Published on: February 17, 2019
Pluripotent stem cell-based cancer therapy: promise and challenges
Saul J Sharkis1, Richard J Jones, Curt Civin
1Department of Oncology, The Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD 21231, USA.
Science Translational Medicine
|March 31, 2012
Summary
Induced pluripotent stem cells (iPSCs) show promise for treating diseases like cancer. However, clinical evidence is limited, and significant barriers hinder their therapeutic application.
Area of Science:
- Biomedical research
- Regenerative medicine
- Stem cell biology
Background:
- Induced pluripotent stem cell (iPSC) technology offers potential for disease treatment.
- Significant enthusiasm exists regarding the therapeutic applications of iPSCs.
- Current clinical evidence supporting iPSC utility is limited.
Purpose of the Study:
- To discuss potential therapeutic applications of iPSCs for cancer and other diseases.
- To highlight existing barriers restricting the clinical use of iPSCs.
Main Methods:
- Review of current literature on iPSC technology.
- Analysis of potential therapeutic strategies involving iPSCs.
- Identification and discussion of challenges in iPSC clinical translation.
Main Results:
- iPSCs have potential applications in treating various diseases, including cancer.
- Evidence for the clinical efficacy of iPSCs is currently limited.
- Several barriers impede the widespread therapeutic use of iPSCs.
Conclusions:
- While iPSC technology is promising, further research is needed to overcome clinical barriers.
- The translation of iPSCs into effective therapies requires addressing safety and efficacy concerns.
- Future efforts should focus on advancing iPSC applications for diverse medical conditions.
Related Concept Videos
01:06Induced Pluripotent Stem Cells
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic cells are...
Somatic cells are...
01:13Induced Pluripotent Stem Cells
Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore called induced pluripotent stem...
01:13Induced Pluripotent Stem Cells
Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore called induced pluripotent stem...
02:40Cancer Stem Cells and Tumor Maintenance
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
02:40Cancer Stem Cells and Tumor Maintenance
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
01:22iPS Cell Differentiation
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.